Baicalein combined with a p38 inhibitor (SB203580) significantly reduced glioblastoma cell invasion and was accompanied by downregulation of MMP-2 and MMP-9 and upregulation of TIMP-1 and TIMP-2. This evidence concerns the gene MMP9 and glioblastoma.